Parents clinical trials

Explore recruiting parents clinical trials.

Recruiting parents studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Parents trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

FELICITA - A proof of concept study: open label phase IIa trial evaluating the effect and safety of transplantation of fecal microbiota in children with autism spectrum disorders and gastrointestinal symptoms

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Lung Microbiota’s evolution after use of Nitrous Oxide on pediatric patient needing airway samples - MicroNO

France

Therapeutic exploratory (Phase II) EU CTIS Study details

AntaMIn - Pain reduction for limb injuries in pediatric emergency departments: A Randomised Clinical Trial comparing intranasal Fentanyl or intranasal Ketamine to oral morphine

France

Phase II and Phase III (Integrated) EU CTIS Study details

Continuous antibiotic infusion in children

Finland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Interest of Oxytocin as an Adjuvant Treatment of Psycho-educational Measures in Challenging Behaviors in Children With Autism Spectrum Disorders and Moderate to Severe Intellectual Disability: Feasibility and Safety Study. (OT-DEFI)

France

Phase II and Phase III (Integrated) EU CTIS Study details

A Phase 3 Study to Evaluate Efficacy and Safety of a Single Dose of Exa-cel in Subjects with Severe Sickle Cell Disease, βS/βC Genotype

Italy, France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Parents trials by city

Parents in Toronto Parents in Vancouver Parents in Montreal Parents in Calgary Parents in Edmonton Parents in Ottawa Parents in Winnipeg Parents in Quebec City Parents in Hamilton Parents in Kitchener Parents in London Parents in Halifax Parents in New York Parents in Los Angeles Parents in Chicago Parents in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease